Journals / Türkiye Aile Hekimliği Dergisi / 2013 / Cilt: 17 - Sayı: 1

Development of vestibulotoxicity by streptomycin usage for treatment of oropharyngeal tularemia: a case report

Orofarengeal tularemi tedavisinde streptomisin kullanımına bağlı vestibülotoksisite gelişimi: Olgu sunumu

Pages
26–28
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we presented a case that developed vestibulotoxicity during streptomycin therapy for oropharyngeal tularemia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tularemia is a zoonotic disease caused by Francisella tularensis.
📊
Key Findings & Data:Clinical forms vary according to the place of entry of bacteria.
💡
Conclusion & Impact:In this study, we presented a case that developed vestibulotoxicity during streptomycin therapy for oropharyngeal tularemia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tularemia is a zoonotic disease caused by Francisella tularensis. Clinical forms vary according to the place of entry of bacteria. The main clinical forms are oropharyngeal ulceroglandular, glandular, typhoidal, pneumonic and oculoglandular. The most common form in Turkey is oropharyngeal. Antibiotic therapy should be initiated early in patients diagnosed with tularemia and streptomycin must be the first choice. Gentamicin, doxycycline or ciprofloxacin may be alternative antibiotics. In this study, we presented a case that developed vestibulotoxicity during streptomycin therapy for oropharyngeal tularemia.

Özet

Tularemi, Francisella tularensis’in neden olduğu zoonotik bir hastalıktır. Bakterinin giriş bölgesine göre klinik formlar değişiklik göstermektedir. Tulareminin klinik formları orofarengeal, ülseroglandüler, glandüler, tifoid, pnömonik ve oküloglandüler form olup ülkemizde en çok görülen orofarengeal formdur. Tularemi tanısı konulan hastalarda antibiyotik tedavisine erken başlanmalı ve ilk tercih edilen antibiyotik streptomisin olmalıdır. Alternatif olarak gentamisin, doksisiklin veya siproşoksasin tercih edilebilir. Bu çalışmada orofarengeal tularemi tedavisinde streptomisin kullanımına bağlı vestibülotoksisite gelişen bir olgu sunulmaktadır.

🔖

Cite This Article

ÖZGÜNEŞ, N., ARIBAL, F. C., YILMAZ, F. K., AKSOY, S. D. (2022). Development of vestibulotoxicity by streptomycin usage for treatment of oropharyngeal tularemia: a case report. Türkiye Aile Hekimliği Dergisi, Cilt: 17 - Sayı: 1, 26–28. https://ajindex.com/articles/626802

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Penn RL. Francisella tularensis (Tularemia). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell Douglas and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 2927-37
  2. Willke A.Tularemi. Ankem Dergisi 2006;20(Suppl.2):222-6
  3. Helvacı S, Gedikoğlu S, Akalın H, Oral HB. Tularemia in Bursa,Turkey: 205 cases in ten years. Eur J Epidemiol 2000;16:271-6
  4. Who guideline on Tularaemia (Internet): Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/tularemia/ resources/whotularemiamanual. pdf/Eriflim tarihi: 2/2/2011 5. Akalın H, Helvacı S, Gedikoğlu S. Re-emergence of tularemia in Turkey. Int J Infect Dis 2009;13:547-51
  5. Willke Topçu A. Aminoglikozitler. In: Willke Topçu A, Söyletir G, Doğanay M, editors. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. 3. baskı. İstanbul: Nobel Tıp Kitabevleri; 2008. s. 294-303
  6. Engin A, Altuntafl EE, Cankorkmaz L ve ark. Sivas ilinde saptanan ilk tularemi salgını: 29 olgunun değerlendirilmesi. Klimik Dergisi 2011;24: 17-23
  7. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 1994;19:42-7
  8. Guthrie OW. Aminoglycoside induced ototoxicity. Toxicology 2008;249: 91-5
  9. Rizzi MD, Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 2007;15:352-7
  10. Gilbert DN, Leggett JE. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone; 2010. p. 359-84. 12. fiahin Ü, Döner F, Koflar A, Arslan A, Tahan V. Streptomisin tedavisine bağlı ototoksisite ve nefrotoksite (olgu sunumu). SDÜ Tıp Fakültesi Dergisi 1996;3:87-9
  11. Peloquin CA, Berning SE, Nitta AT et al. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis 2004;38:1538-44.